Clin2
NCT06250842Possibly a fitRecruiting

Benzodiazepine impact on brain function study

Benzodiazepine Adverse ReactionDepression, AnxietyBenzodiazepine Dependence

Part of Mental health clinical trials.

This study uses brain scans to understand how long-term benzodiazepine use affects thinking and memory. It compares people who have taken benzodiazepines for at least 3 months with those who have not.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years to 80 years
Study type
Observational

Who can take part

  • You have taken benzodiazepines continuously for 3 months or longer
  • You have at least 6 years of education
  • You have not had alcohol, coffee, or other psychoactive substances in the 24 hours before the exam
  • You do not have brain damage, severe illness, or recent stroke
  • You do not have a history of substance abuse (other than benzodiazepines)
  • You can cooperate with brain scans and assessments

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06004115Recruiting· Phase 4
Brain scanning study for depression and anxiety

This study uses brain scans (fMRI) to understand how people with both depression and anxiety respond to threat. If you have either or both conditions, participating could help researchers find better treatments.

Tulsa, Oklahoma
NCT05935553Recruiting· Phase 2/Phase 3
Baclofen to help taper benzodiazepines more safely

This trial tests whether baclofen can make it easier to reduce (taper) benzodiazepines in people who have been dependent for a long time and previously had trouble stopping. If you can safely take part, it may help improve the tapering process and reduce withdrawal problems.

Bron
NCT02108080Recruiting
Study of brain imaging in people with alcohol use disorder

This study collects natural history information and brain imaging (MRI) using an imaging instrument to compare people with alcohol use disorder and people without. It may help researchers understand how brain imaging works in real-world participants and how it relates to alcohol-related health.

Bethesda, Maryland
NCT07290205Recruiting· Early Phase 1
Remimazolam brain imaging study

This study uses brain scans to see how a new sedative called remimazolam affects the brain in healthy adults. It will help researchers understand the drug's effects and ensure it's safe.

Pittsburgh, Pennsylvania
NCT06467019Recruiting
Reducing benzodiazepine use with educational information

This trial tests if showing educational information to people about reducing or stopping benzodiazepines (a type of sleep or anxiety medication) helps them safely use less. You may be able to join if you're an adult patient at this specific clinic and not already in a similar study.

Vilanova i la Geltrú, Barcelona
NCT06446349Recruiting
Helping reduce long-term use of benzodiazepine or Z-drugs

This study tests whether a brief motivational interview can help people safely reduce or stop taking benzodiazepines or Z-drugs (like sleeping pills or anxiety meds) they have used daily for at least 6 months. It aims to support patients in trying to lower their dose with their doctor's guidance.

Annonay

Hear when a new Depression, Anxiety trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.